Tanke Biosciences Corp (TNBI) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Total · absolute moveSwitch to Alpha · OTC
Tanke Biosciences Corp (TNBI) stock forecast summary
This forecast was produced 3 trading days ago and has not been refreshed since; read it as historical, not as a current view.
Its market capitalization is not available, so no size classification is given.
A per-ticker accuracy statistic for TNBI is published only once its sample size is known. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +5.1%, buy ≥ +3.4%, sell < +1.8%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
TNBI price chart and AI forecast
How TNBI ranks among 5185 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Tanke Biosciences Corp (TNBI) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Grain Mill Products peers listed below that report each metric.
Valuation & Market
| Metric | TNBI | Rank |
|---|---|---|
| EPS | $-0.07 | – |
Profitability & Margins
| Metric | TNBI | Rank |
|---|---|---|
| Tax Rate | 75.2% | – |
The effective tax rate is outside the normal band, which points to a large non-recurring tax item in the trailing twelve months; headline net income, net margin and P/E are affected by it.
Financial Health
| Metric | TNBI | Rank |
|---|---|---|
| D/E Ratio | 0.84x | 3/5 |
| Financial Leverage | 1.85x | 3/5 |
| Interest Coverage | 11.4x | 1/5 |
Cash Flow
| Metric | TNBI | Rank |
|---|---|---|
| Operating Cash Flow | $3M | 5/5 |
Income Statement
| Metric | TNBI | Rank |
|---|---|---|
| Operating Income | $1M | 4/5 |
| SG&A Expense | $7M | – |
| Cost of Goods Sold | $13M | 5/5 |
Dividend & Shareholder Information
| Metric | TNBI | Rank |
|---|---|---|
| EPS Growth | -233.3% | 5/5 |
Balance Sheet Highlights (USD millions)
| Total Liabilities | $13M |
TNBI quarterly financials and insider trading
Tanke Biosciences Corp (TNBI) industry peers
Companies classified under the same SEC industry code as Tanke Biosciences Corp (Grain Mill Products): 5 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWhere TNBI sits on the market map
Tanke Biosciences Corp (TNBI) stock news
Loading...
Tanke Biosciences Corp (TNBI) stock forecast FAQ
What is the Tanke Biosciences Corp (TNBI) stock forecast?
This forecast was produced 3 trading days ago and has not been refreshed since; read it as historical, not as a current view.
How accurate are Tanke Biosciences Corp stock predictions?
A per-ticker accuracy statistic for TNBI is published only once its sample size is known. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Tanke Biosciences Corp forecasts updated?
Tanke Biosciences Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Tanke Biosciences Corp's industry peers?
5 issuers in our coverage, TNBI included, share the SEC industry code Grain Mill Products. The largest are: General Mills Inc (GIS), Ingredion Inc (INGR), Post Holdings, Inc. (POST), Freshpet, Inc. (FRPT).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.